Compound ID | 2964

Update compound information

REDX07623

Class: DNA synthesis inhibitor

Agent Type: Synthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive & Gram-negative
Mechanism of action: DNA synthesis inhibitor. Bacterial topoisomerase inhibitor
Target Pathogen: Active against Acinetobacter baumannii, Clostridium difficile, Enterobacter cloacae, Enterococcus faecium, Enterococcus faecalis, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, Bacillus anthracis, Francisella tularensis, and Yersinia pestis
Description: Synthetic compound; cytotoxicity (IC50) towards mammalian cell line HepG2 at 38 ug/ml vs MIC at 4-0.12 ug/ml
Institute where first reported: Redx Pharma, Alderley Park, Cheshire, United Kingdom
Year first mentioned: 2017
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 510.49
Iso. SMILES: FC1=CC=C2C(N(CCN3CCC(NCC4=NC=5NC(COC5C=C4F)=O)CC3)C(C6=NOC=C62)=O)=C1
InChI Key: WHPBMCINENAEFN-UHFFFAOYSA-N
Can. SMILES: C1=CC2=C(C=C1F)N(CCN3CCC(CC3)NCC4=C(C=C5C(=N4)NC(=O)CO5)F)C(=O)C6=NOC=C26
InChI: InChI=1S/C25H24F2N6O4/c26-14-1-2-16-17-12-37-31-23(17)25(35)33(20(16)9-14)8-7-32-5-3-15(4-6-32)28-11-19-18(27)10-21-24(29-19)30-22(34)13-36-21/h1-2,9-10,12,15,28H,3-8,11,13H2,(H,29,30,34)
External links:
Citation: https://journals.asm.org/doi/10.1128/aac.02100-16

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.